Dr Elizabeth Christie
Honorary Conjoint Senior Fellow
The Sir Peter MacCallum Department of Oncology
95 Scholarly works
14 Projects
HIGHLIGHTS
2026
Journal article
Clinicopathologic and molecular predictors of survival in BRCA-deficient tubo-ovarian high-grade serous carcinoma
DOI: 10.1038/s41467-026-71134-32026
Journal article
Perioperative ctDNA as a prognostic biomarker in endometrial cancer - the CODEC study
DOI: 10.1016/j.tranon.2026.1028712026
Journal article
Using polygenic risk scores to refine risk and outcomes in high-grade serous ovarian cancer in Australia.
DOI: 10.1158/1055-9965.EPI-25-18822026
Research grants (ARC, NHMRC, MRFF)
Driving Cancer Discoveries Through Integration of ‘Omics and Clinical Data
2024
Research grants (international)
Improving Ovarian Cancer Outcomes by Understanding and Targeting Acquired Resistance
2019
Research Grant
Molecular and Spatial Characterization of Drug Resistance in Human Ovarian Cancer
2015
Journal article
Whole-genome characterization of chemoresistant ovarian cancer
DOI: 10.1038/nature14410
RECENT SCHOLARLY WORKS
2026
Journal article
DNA methylation profiling enables subclassification of mucinous ovarian carcinoma and distinguishes it from extraovarian mucinous metastases.
DOI: 10.1016/j.xcrm.2026.1029412026
Journal article
Epigenetic drivers of FOLR expression in high grade serous carcinoma
DOI: 10.1016/j.ygyno.2026.01.0232026
Journal article
Comparison of homologous recombination deficiency scoring methods in multi-site samples in high grade serous ovarian cancer
DOI: 10.1016/j.ijgc.2025.1042332025
Journal article
Biology of ovarian cancer: Models, microenvironment, and therapeutics: 15th Biennial Rivkin Center Ovarian Cancer Research Symposium
DOI: 10.1016/j.ygyno.2025.08.0142025
Journal article
Abstract B004: Evaluating spatial inter-tumor heterogeneity in whole genome duplication states and homologous recombination deficiency status in advanced ovarian high grade serous carcinoma
DOI: 10.1158/1538-7445.ovarian25-b0042025
Journal article
Abstract PR019: Characterizing resistance at single cell resolution in HR deficient HGSOC
DOI: 10.1158/1538-7445.ovarian25-pr0192025
Journal article
Genome doubling fuels ovarian cancer evolution and immune dysregulation
DOI: 10.1038/d41586-025-02059-y
RECENT PROJECTS
2026
Research grants (ARC, NHMRC, MRFF)
Identifying the Key to Treatment Resistance in Ovarian Cancer